Edwards Lifesciences EW Other countries — Tax Benefit Amount

Similar metrics at other companies

NTAPOther Countries — Foreign Income Tax Expense Benefit Continuing Operations

$17.5M—

ENBOther Countries — Foreign Income Tax Expense Benefit Continuing Operations

-200,000,000%-3,400,000,000pp

AESNon-US — Income Tax Expense (Benefit)

$6.5M-7.1%

RLGTForeign

$365K-28.8%

NOVTOther Countries — Current Income Tax Expense Benefit

$5.73M+16.7%

CHE

CHENon-U.S.

$101.5K-19.0%

Questions, answered.

What is Edwards Lifesciences's other countries — tax benefit amount?

Edwards Lifesciences (EW) reported other countries — tax benefit amount of $104.5M in Q4 2025.

How has Edwards Lifesciences's other countries — tax benefit amount changed year-over-year?

Edwards Lifesciences's other countries — tax benefit amount increased by 17.0% year-over-year, from $89.3M to $104.5M.

What does other countries — tax benefit amount mean?

The specific tax benefit recognized in the financial statements derived from operations in international regions outside the primary domestic market. This metric reflects the impact of tax planning strategies and regional tax incentives on the company's overall effective tax rate.